Mutations in BRCA1 (breast cancer 1, early onset; MIM#113705) and BRCA2 (Breast Cancer Type 2 susceptibility protein; MIM#600185) account for an autosomal dominant transmission of susceptibility to breast and ovarian cancer. This evidence concerns the gene BRCA1 and ovarian carcinoma.